The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children

Journal of Infectious Diseases

Volumn 199, Issue 1, 2009, Pages 31-38

  Njie, Ramou ^a,b   Bell, Andrew I ^a   Jia, Hui ^a   Croom Carter, Debbie ^a   Chaganti, Sridhar ^a   Hislop, Andrew D ^a   Whittle, Hilton ^b   Rickinson, Alan B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR; GAMMA INTERFERON; HLA B ANTIGEN; QUININE;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLELE; ARTICLE; BURKITT LYMPHOMA; CANCER SUSCEPTIBILITY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; GAMBIA; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALARIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED KINGDOM; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS LOAD; VIRUS STRAIN;

ACUTE DISEASE; ADOLESCENT; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; GAMBIA; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MALARIA; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; REFERENCE VALUES; T-LYMPHOCYTES; VIRAL LOAD;

EID: 58749116148     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/594373     Document Type: Article

References (39)

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Fields virology. 5th ed. Vol 2. Philadelphia: Lippincott Williams & Wilkins, 2006:2655-700.
2. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med 2005; 56:29-44.
3. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4:757-68.
4. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990; 55:133-270.
5. Dalldorf G. Lymphomas of African children with different forms or environmental influences. JAMA 1962; 181:1026-8.
6. Rochford R, Cannon MJ, Moormann AM. Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Microbiol 2005; 3:182-7.
7. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001; 1:75-82.
8. Moss DJ, Burrows SR, Castelino DJ, et al. A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and-nonendemic regions of Papua New Guinea. Int J Cancer 1983; 31:727-32.
9. Gudgeon NH, Taylor GS, Long HM, Haigh TA, Rickinson AB. Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity. J Virol 2005; 79:5477-88.
10. Moormann AM, Chelimo K, Sumba PO, Tisch DJ, Rochford R, Kazura JW. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 2007; 195:799-808.
11. Moormann AM, Chelimo K, Sumba OP, et al. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 2005; 191:1233-8.
12. Whittle HC, Brown J, Marsh K, et al. T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 1984; 312:449-50.
13. Whittle HC, Brown J, Marsh K, Blackman M, Jobe O, Shenton F. The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children. Clin Exp Immunol 1990; 80:213-8.
14. Lam KM, Syed N, Whittle H, Crawford DH. Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 1991; 337:876-8.
15. Rasti N, Falk KI, Donati D, et al. Circulating Epstein-Barr virus in children living in malaria-endemic areas. Scand J Immunol 2005; 61:461-5.
16. Donati D, Espmark E, Kironde F, et al. Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. J Infect Dis 2006; 193:971-7.
17. Yone CL, Kube D, Kremsner PG, Luty AJ. Persistent Epstein-Barr viral reactivation in young African children with a history of severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2006; 100:669-76.
18. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 2006; 103:7065-70.
19. Junying J, Herrmann K, Davies G, et al. Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology 2003; 306:236-43.
20. Sample J, Young L, Martin B, et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990; 64:4084-92.
21. Brooks JM, Croom-Carter DS, Leese AM, Tierney RJ, Habeshaw G, Rickinson AB. Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains. J Virol 2000; 74:1801-9.
22. Tan LC, Gudgeon N, Annels NE, et al. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol 1999; 162:1827-35.
23. Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007; 25:587-617.
24. Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 1978; 22:239-43.
25. Geser A, Brubaker G, Olwit GW. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa. Rev Epidemiol Sante Publique 1980; 28:307-21.
26. Duraiswamy J, Burrows JM, Bharadwaj M, et al. Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. J Virol 2003; 77:7401-10.
27. Midgley RS, Bell AI, McGeoch DJ, Rickinson AB. Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. J Virol 2003; 77:11517-30.
28. Blake N, Haigh T, Shaka'a G, Croom-Carter D, Rickinson A. The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1. J Immunol 2000; 165:7078-87.
29. Donati D, Mok B, Chene A, et al. Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J Immunol 2006; 177:3035-44.
30. Chene A, Donati D, Guerreiro-Cacais AO, et al. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog 2007; 3:e80.
31. Rickinson AB, Jarvis JE, Crawford DH, Epstein MA. Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis. Int J Cancer 1974; 14:704-15.
32. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity 1998; 9:395-404.
33. Meij P, van Esser JW, Niesters HG, et al. Impaired recovery of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood 2003; 101:4290-7.
34. Piriou ER, van Dort K, Nanlohy NM, Miedema F, van Oers MH, van Baarle D. Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma. J Immunol 2004; 172:6931-7.
35. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309:453-8.
36. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2004; 2:11-21.
37. Ioachim HL, Cronin W, Roy M, Maya M. Persistent lymphadenopathies in people at high risk for HIV infection: clinicopathologic correlations and long-term follow-up in 79 cases. Am J Clin Pathol 1990; 93:208-18.
38. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005; 5:251-62.
39. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 2007; 99:962-72.